Volcano Receives CE Mark for iFR Scout Pullback Software to Help Diagnose Serial Lesions and Diffuse Coronary Disease

Royal Philips (NYSE: PHG; AEX: PHIA), today announced that Volcano, a Philips business, has received CE Mark for the iFR Scout pullback software, a functional extension of its existing iFR Modality, optimized to assess serial lesions and diffuse coronary disease. Limited Market Release will commence immediately at leading European and Japanese medical centers. This software is currently pending 510(k) clearance at the US FDA. It is not available for sale in the US.

Source: News from Angioplasty.Org - April 10, 2015 Category: Cardiology Source Type: news